dronabinol has been researched along with scopolamine hydrobromide in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (29.63) | 18.7374 |
| 1990's | 6 (22.22) | 18.2507 |
| 2000's | 10 (37.04) | 29.6817 |
| 2010's | 3 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Atweh, S; Kuhar, MJ; Simon, JR | 1 |
| Bateman, DN; Campbell, M | 1 |
| Pertwee, RG; Ross, TM | 1 |
| Iversen, SD; Rupniak, NM; Samson, NA; Steventon, MJ | 1 |
| Appel, JB; Cameron, OG | 1 |
| Henriksson, BG; Järbe, TU | 1 |
| Brown, H | 1 |
| Drew, WG; Miller, LL; Wikler, A | 1 |
| Baugh, EL; Drew, WG; Miller, LL | 1 |
| Davis, JM; el-Yousef, MK; Janowsky, DS; Rosenblatt, JE | 1 |
| Waser, PG | 1 |
| Hasegawa, T; Kameyama, T; Kinoshita, H; Nabeshima, T; Yamamoto, I | 1 |
| Lichtman, AH; Martin, BR | 1 |
| Presburger, G; Robinson, JK | 1 |
| Moerschbaecher, JM; Nakamura-Palacios, EM; Winsauer, PJ | 1 |
| Hamm, RJ; Lichtman, AH; Martin, BR; Varvel, SA | 1 |
| Egashira, N; Fujii, M; Fujiwara, M; Hirosawa, N; Iwasaki, K; Matsumoto, Y; Mishima, K | 1 |
| Caboche, J; Girault, JA; Hervé, D; Pagès, C; Valjent, E | 1 |
| Brown, CM; Lu, D; Makriyannis, A; McLaughlin, PJ; Salamone, JD; Thakur, G; Winston, KM | 1 |
| Egashira, N; Fujioka, M; Fujiwara, M; Iwasaki, K; Matsumoto, Y; Matsushita, M; Mishima, K; Nishimura, R; Shoyama, Y | 1 |
| Egashira, N; Fujiwara, M; Iwasaki, K; Kurauchi, K; Manome, N; Matsumoto, Y; Mishima, K; Shoyama, Y | 1 |
| Fratta, W; Goldberg, SR; Scherma, M; Solinas, M; Tanda, G; Wertheim, CE | 1 |
| Burston, JJ; Wiley, JL | 1 |
| Goldberg, SR; Panlilio, LV; Schindler, CW; Thorndike, EB; Yasar, S | 1 |
2 review(s) available for dronabinol and scopolamine hydrobromide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacokinetic optimisation of antiemetic therapy.
Topics: Adrenal Cortex Hormones; Antiemetics; Benzodiazepines; Dopamine Antagonists; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Histamine H1 Antagonists; Humans; Phenothiazines; Scopolamine; Serotonin Antagonists | 1992 |
25 other study(ies) available for dronabinol and scopolamine hydrobromide
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Utilization of sodium-dependent high affinity choline uptake in vitro as a measure of the activity of cholinergic neurons in vivo.
Topics: Animals; Atropine; Biological Transport, Active; Brain; Cell-Free System; Cerebral Cortex; Choline; Corpus Striatum; Dronabinol; Haloperidol; Hippocampus; Male; Mice; Morphine; Neurons; Pentobarbital; Pentylenetetrazole; Rats; Scopolamine; Sodium; Synaptosomes | 1975 |
Drugs which stimulate or facilitate central cholinergic transmission interact synergistically with delta-9-tetrahydrocannabinol to produce marked catalepsy in mice.
Topics: Acetylcholine; Animals; Atropine; Atropine Derivatives; Body Temperature; Catalepsy; Dronabinol; Drug Synergism; Male; Mice; Mice, Inbred Strains; Neostigmine; Oxotremorine; Parasympathomimetics; Physostigmine; Scopolamine; Synaptic Transmission | 1991 |
Induction of cognitive impairment by scopolamine and noncholinergic agents in rhesus monkeys.
Topics: Amphetamine; Animals; Behavior, Animal; Cognition; Dronabinol; Lorazepam; Macaca mulatta; Male; Morphine; Phencyclidine; Scopolamine; Spatial Behavior; Yohimbine | 1991 |
A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats.
Topics: Animals; Behavior, Animal; Chlorpromazine; Dextroamphetamine; Discrimination Learning; Discrimination, Psychological; Dronabinol; Fenclonine; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Rats; Scopolamine | 1973 |
Discriminative response control produced with hashish, tetrahydrocannabinols (delta 8-THC and delta 9-THC), and other drugs.
Topics: Amphetamine; Animals; Atropine; Avoidance Learning; Cannabis; Chlordiazepoxide; Chlorpromazine; Choice Behavior; Cocaine; Cues; Diazepam; Discrimination, Psychological; Dronabinol; Ketamine; Levallorphan; Male; Morphine; Pentobarbital; Phencyclidine; Physostigmine; Psilocybin; Rats; Scopolamine; Transfer, Psychology; Yohimbine | 1974 |
Possible anticholinesterase-like effects of trans(-) 8 and - 9 tetrahydrocannabinol as observed in the general motor activity of mice.
Topics: Acridines; Animals; Behavior, Animal; Benzopyrans; Cannabis; Cholinesterase Inhibitors; Dronabinol; Drug Antagonism; Drug Combinations; Drug Synergism; Glycolates; Male; Mice; Motor Activity; Pentobarbital; Physostigmine; Piperidines; Pyrrolidines; Scopolamine | 1972 |
Comparison of 9 -THC, LSD-25 and scopolamine on non-spatial single alternation performance in the runway.
Topics: Animals; Behavior, Animal; Cannabis; Conditioning, Psychological; Cues; Dronabinol; Lysergic Acid Diethylamide; Male; Rats; Reward; Scopolamine; Task Performance and Analysis; Time Factors | 1973 |
Effects of delta9-THC, LSD-25 and scopolamine on continuous, spontaneous alternation in the Y-maze.
Topics: Animals; Cannabis; Dose-Response Relationship, Drug; Dronabinol; Learning; Lysergic Acid Diethylamide; Male; Rats; Scopolamine; Stimulation, Chemical | 1973 |
The augmentation of physostigmine toxicity in the rat by 9 -tetrahydrocannabinol.
Topics: Animals; Atropine; Cannabis; Dronabinol; Drug Combinations; Drug Synergism; Injections, Intravenous; Physostigmine; Rats; Scopolamine | 1972 |
[Pharmacological action spectra of hallucinogens].
Topics: Amphetamine; Animals; Atropine; Autonomic Nervous System; Brain; Dronabinol; Hallucinogens; Learning; Lysergic Acid Diethylamide; Mental Processes; Mescaline; Psilocybin; Rats; Scopolamine | 1971 |
Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
Topics: 2-Amino-5-phosphonovalerate; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amantadine; Amino Acids; Animals; Anticonvulsants; Catalepsy; Dizocilpine Maleate; Dopamine Agonists; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Ergolines; Haloperidol; Male; Mice; Mice, Inbred Strains; Motor Activity; Piperazines; Quinpirole; Receptors, N-Methyl-D-Aspartate; Scopolamine | 1994 |
Delta 9-tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism.
Topics: Animals; Dronabinol; Male; Maze Learning; Memory; Physostigmine; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Scopolamine | 1996 |
Spatial signal detection in rats is differentially disrupted by delta-9-tetrahydrocannabinol, scopolamine, and MK-801.
Topics: Animals; Attention; Cues; Depression, Chemical; Dizocilpine Maleate; Dronabinol; Excitatory Amino Acid Antagonists; Hallucinogens; Injections, Intravenous; Male; Muscarinic Antagonists; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Scopolamine; Signal Detection, Psychological; Space Perception | 1999 |
Effects of the cannabinoid ligand SR 141716A alone or in combination with delta9-tetrahydrocannabinol or scopolamine on learning in squirrel monkeys.
Topics: Animals; Dose-Response Relationship, Drug; Dronabinol; Female; Hallucinogens; Learning; Ligands; Muscarinic Antagonists; Piperidines; Pyrazoles; Rimonabant; Saimiri; Scopolamine | 2000 |
Differential effects of delta 9-THC on spatial reference and working memory in mice.
Topics: Animals; Dose-Response Relationship, Drug; Dronabinol; Hallucinogens; Male; Memory; Mice; Mice, Inbred C57BL; Muscarinic Antagonists; Phencyclidine; Psychotropic Drugs; Receptors, Cannabinoid; Receptors, Drug; Scopolamine; Spatial Behavior | 2001 |
Characteristics of learning and memory impairment induced by delta9-tetrahydrocannabinol in rats.
Topics: Animals; Avoidance Learning; Discrimination Learning; Dronabinol; Hallucinogens; Injections, Intraventricular; Learning Disabilities; Maze Learning; Memory Disorders; Memory, Short-Term; Muscarinic Agonists; Muscarinic Antagonists; Pilocarpine; Piperidines; Pyrazoles; Rats; Rimonabant; Scopolamine | 2001 |
Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain.
Topics: Adrenergic Uptake Inhibitors; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Benzazepines; Brain; Caffeine; Central Nervous System Stimulants; Cocaine; Desipramine; Dopamine Antagonists; Dronabinol; Enzyme Activation; Fluoxetine; Immunohistochemistry; Male; Mice; Mitogen-Activated Protein Kinases; Morphine; Muscarinic Antagonists; Neurons; Nicotine; Nicotinic Agonists; Scopolamine; Selective Serotonin Reuptake Inhibitors | 2004 |
The novel cannabinoid agonist AM 411 produces a biphasic effect on accuracy in a visual target detection task in rats.
Topics: Adamantane; Animals; Dose-Response Relationship, Drug; Dronabinol; Mice; Muscarinic Antagonists; Pattern Recognition, Visual; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Scopolamine; Task Performance and Analysis | 2005 |
Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilization.
Topics: Animals; Brain Chemistry; Citalopram; Dronabinol; Electroshock; Hallucinogens; Male; Memory Disorders; Microdialysis; Muscarinic Agonists; Oxotremorine; Parasympathetic Nervous System; Rats; Rats, Wistar; Scopolamine; Selective Serotonin Reuptake Inhibitors; Tremor | 2006 |
Kamikihi-to, a Kampo medicine, ameliorates impairment of spatial memory in rats.
Topics: Animals; Dronabinol; Drugs, Chinese Herbal; Male; Maze Learning; Medicine, Kampo; Memory; Memory Disorders; Mice; Mice, Inbred Strains; Oxotremorine; Rats; Rats, Wistar; Scopolamine; Tremor | 2007 |
Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
Topics: Animals; Arachidonic Acids; Discrimination, Psychological; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Endocannabinoids; Enzyme Inhibitors; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mecamylamine; Muscarinic Agonists; Muscarinic Antagonists; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pilocarpine; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Reaction Time; Receptor, Cannabinoid, CB1; Receptors, Muscarinic; Receptors, Nicotinic; Reinforcement, Psychology; Scopolamine | 2007 |
Chronic Delta9-tetrahydrocannabinol during adolescence increases sensitivity to subsequent cannabinoid effects in delayed nonmatch-to-position in rats.
Topics: Age Factors; Amphetamine; Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Choice Behavior; Conditioning, Operant; Dopamine Uptake Inhibitors; Dronabinol; Drug Interactions; Endocannabinoids; Male; Muscarinic Antagonists; Polyunsaturated Alkamides; Psychotropic Drugs; Rats; Rats, Long-Evans; Scopolamine; Time Factors | 2010 |
Automatic recording of mediating behavior in delayed matching- and nonmatching-to-position procedures in rats.
Topics: Animals; Behavior, Animal; Cues; Dose-Response Relationship, Drug; Dronabinol; Male; Memory; Odds Ratio; Psychotropic Drugs; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Reaction Time; Scopolamine; Time Factors | 2011 |